Follow

Submissions from 2020

PDF

Case report of ablative magnetic resonance-guided stereotactic body radiation therapy for oligometastatic mesenteric lymph nodes from bladder cancer, Michael Chuong, Diane Alvarez, Tino Romaguera, Kathyrn Mittauer, Sonia Adamson, Alonso Gutierrez, Gustavo Luciani, Hayden Guerrero Olmo, and Antonio Ucar
Open Access

PDF

Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation, Guenther Koehne
Full Text Restricted – Available from BHSF IP or login only

PDF

Prognostic Factors for Post-Relapse Survival after ex-vivo CD34(+)-Selected (T cell-depleted) Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma, Guenther Koehne
Full Text Restricted – Available from BHSF IP or login only

PDF

Melflufen plus dexamethasone in relapsed and refractory multiple myeloma (O-12-M1): a multicentre, international, open-label, phase 1-2 study, Claudia Paba Prada
Full Text Restricted – Available from BHSF IP or login only

PDF

Revisiting Early Palliative Care for Patients With Hematologic Malignancies and Bone Marrow Transplant: Why the Delay?, Marco Ruiz Andia
Open Access

PDF

A Phase II Trial of Albumin-Bound Paclitaxel and Gemcitabine in Patients with Newly Diagnosed Stage IV Squamous Cell Lung Cancers, Miguel Villalona Calero
Full Text Restricted – Available from BHSF IP or login only

PDF

Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]-Fluorothymidine Positron Emission Tomography Biomarker Study, Miguel Villalona Calero
Open Access

Submissions from 2019

PDF

Complications of Intrathecal Chemotherapy in Adults: Single-Institution Experience in 109 Consecutive Patients, Fernando Vargas Madueno
Open Access

PDF

Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non-small Cell Lung Cancer, Miguel Villalona Calero
Full Text Restricted – Available from BHSF IP or login only

PDF

Type of TP53 mutation influences oncogenic potential and spectrum of associated K-ras mutations in lung-specific transgenic mice, Miguel Villalona Calero
Full Text Restricted – Available from BHSF IP or login only

Submissions from 2018

PDF

How I treat the young patient with multiple myeloma, Claudia Paba Prada
Full Text Restricted – Available from BHSF IP or login only

PDF

Platelet Transfusion for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update, Michael Troner
Full Text Restricted – Available from BHSF IP or login only

PDF

EML4-ALK Rearrangement and Its Therapeutic Implications in Inflammatory Myofibroblastic Tumors, Fernando Vargas Madueno, Edwin Gould, Raul Valor, and Miguel Villalona Calero
Full Text Restricted – Available from BHSF IP or login only

PDF

Incidence, Risk Factors, and Effect on Survival of Immune-related Adverse Events in Patients With Non-Small-cell Lung Cancer, Miguel Villalona Calero
Open Access

PDF

Phase II randomized, double-blind, placebo-controlled study of tivantinib in men with asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC), Miguel Villalona Calero
Full Text Restricted – Available from BHSF IP or login only

PDF

Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden, Miguel Villalona Calero and Zuanel Diaz
Open Access

Submissions from 2016

Global Overview of Colorectal Cancer ― Past, Present and Future, Antonio Ucar

PDF

Clinical Cancer Advances 2016: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology, Miguel Villalona Calero
Full Text Restricted – Available from BHSF IP or login only

PDF

Veliparib Alone or in Combination with Mitomycin C in Patients with Solid Tumors With Functional Deficiency in Homologous Recombination Repair, Miguel Villalona Calero
Full Text Restricted – Available from BHSF IP or login only